Medite Cancer Diagnostics, Inc.

OTCPK:MDIT Stock Report

Market Cap: US$8.6k

Medite Cancer Diagnostics Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Medite Cancer Diagnostics's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2018

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown
Beta

How Medite Cancer Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:MDIT Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 188-551
30 Jun 187-651
31 Mar 186-751
31 Dec 177-751
30 Sep 177-542
30 Jun 177-441
31 Mar 179-342
31 Dec 169-241
30 Sep 1610-232
30 Jun 1610-131
31 Mar 1610-131
31 Dec 1510-131
30 Sep 159-121
30 Jun 159-121
31 Mar 1511-131
31 Dec 1411-131
30 Sep 1412031
30 Jun 1411031
31 Mar 1411031
31 Dec 1310031

Quality Earnings: Insufficient data to determine if MDIT has high quality earnings.

Growing Profit Margin: Insufficient data to determine if MDIT's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MDIT's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare MDIT's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if MDIT's earnings growth over the past year exceeded the Medical Equipment industry average.


Return on Equity

High ROE: MDIT has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.